Literature DB >> 8203201

Prevention of recurrent acute otitis media in otitis-prone children by intermittent prophylaxis with penicillin.

K Prellner1, M Foglé-Hansson, F Jørgensen, O Kalm, C Kamme.   

Abstract

The question whether penicillin V (pcV) given intermittently upon signs of upper respiratory tract infections (URTI) in otitis-prone children might prevent recurrent bouts of acute purulent otitis media (AOM) is addressed. As compared with continuous long-term antibiotic treatment as prophylaxis in otitis-prone children, intermittent administration would reduce the overall consumption of antibiotics. Seventy-six otitis-prone children less than 18 months of age were included in this double-blind, randomized, placebo-controlled multicentre study. Follow-up was from January till June. One hundred and twenty-three episodes of AOM occurred. The number of AOM episodes was reduced by 50% in the children on pcV during URTI episodes as compared with those on placebo. No obvious ecological drawbacks were noted. Thus, the described mode of pcV administration seems to be a rational and safe way to reduce the number of AOM episodes in otitis-prone children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203201     DOI: 10.3109/00016489409126039

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

1.  Acute otitis media. Norwegian consensus is that only children with recurrent episodes of otitis media need antibiotics.

Authors:  M Lindbaek
Journal:  BMJ       Date:  2000-01-15

Review 2.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

3.  Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial.

Authors:  K Roos; E G Håkansson; S Holm
Journal:  BMJ       Date:  2001-01-27

4.  Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children.

Authors:  P Marchisio; N Principi; E Sala; L Lanzoni; S Sorella; A Massimini
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  Longer term outcomes from a randomised trial of prescribing strategies in otitis media.

Authors:  Paul Little; Michael Moore; Greg Warner; Joan Dunleavy; Ian Williamson
Journal:  Br J Gen Pract       Date:  2006-03       Impact factor: 5.386

6.  Turnover of nonencapsulated Haemophilus influenzae in the nasopharynges of otitis-prone children.

Authors:  A Samuelson; A Freijd; J Jonasson; A A Lindberg
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.